Constitutive STAT3 phosphorylation and IL-6/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patients
- 19 March 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cellular & Molecular Immunology
- Vol. 16 (3), 275-287
- https://doi.org/10.1038/cmi.2018.5
Abstract
T-cells critically contribute to protection against Mycobacterium tuberculosis infection, and impaired T-cell responses can lead to disease progression. Pro-inflammatory and immunosuppressive cytokines affect T-cells, and fine-tuned regulation of cytokine signaling via the Jak/STAT signaling pathways is crucial for appropriate T-cell function. Constitutive STAT3 phosphorylation as a consequence of aberrant cytokine signaling has been described to occur in pathognomonic T-cell responses in inflammatory and autoimmune diseases. We characterized blood samples from tuberculosis patients (n=28) and healthy contacts (n=28) from Ghana for M. tuberculosis-specific T-cell responses, constitutive cytokine production, and SOCS3 and pSTAT3 expression. Lentiviral modulation of primary CD4+ T-cells was performed to determine the effects of SOCS3 on T-cell functions. T-cells from tuberculosis patients expressed higher levels of IL-10 and IL-6 and lower levels of T helper type (TH)17 cytokines after M. tuberculosis-specific stimulation compared to healthy contacts. In addition, tuberculosis patients had higher IL-10 and IL-6 levels in the supernatants of non-stimulated immune cells and plasma samples compared to healthy contacts. Notably, aberrant cytokine expression was accompanied by high constitutive pSTAT3 levels and SOCS3 expression in T-cells. Multivariate analysis identified an IL-6/IL-10 co-expression-based principal component in tuberculosis patients that correlated with high pSTAT3 levels. SOCS3 contributed to a regulatory component, and tuberculosis patients with high SOCS3 expression showed decreased TH1 cytokine expression and impaired IL-2-induced STAT5 phosphorylation. SOCS3 over-expression in primary CD4+ T-cells confirmed the SOCS3 inhibitory function on IL-2-induced STAT5 phosphorylation. We conclude that constitutive pSTAT3 and high SOCS3 expression are influential factors that indicate impaired T-cell functions in tuberculosis patients.Keywords
This publication has 60 references indexed in Scilit:
- Interleukin (IL-6) ImmunotherapyCold Spring Harbor Perspectives in Biology, 2017
- Constitutive STAT3 Phosphorylation in Circulating CD4+ T Lymphocytes Associates with Disease Activity and Treatment Response in Recent-Onset Rheumatoid ArthritisPLOS ONE, 2015
- SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosisSeminars in Immunology, 2014
- Phosphorylated STAT3 and PD‐1 regulate IL‐17 production and IL‐23 receptor expression in Mycobacterium tuberculosis infectionEuropean Journal of Immunology, 2014
- SOCS3 promotes interleukin-17 expression of human T cellsBlood, 2012
- The IL-23/IL-17 axis in inflammationJCI Insight, 2006
- Intrinsic Functional Dysregulation of CD4 T Cells Occurs Rapidly following Persistent Viral InfectionJournal of Virology, 2005
- SOCS3 regulates the plasticity of gp130 signalingNature Immunology, 2003
- Cutting Edge: Suppressor of Cytokine Signaling 3 Inhibits Activation of NFATpThe Journal of Immunology, 2002
- Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatmentClinical and Experimental Immunology, 1999